Helicobacter pylori and Gastric Cancer: Adaptive Cellular Mechanisms Involved in Disease Progression
- PMID: 29403459
- PMCID: PMC5786524
- DOI: 10.3389/fmicb.2018.00005
Helicobacter pylori and Gastric Cancer: Adaptive Cellular Mechanisms Involved in Disease Progression
Abstract
Helicobacter pylori (H. pylori) infection is the major risk factor associated with the development of gastric cancer. The transition from normal mucosa to non-atrophic gastritis, triggered primarily by H. pylori infection, initiates precancerous lesions which may then progress to atrophic gastritis and intestinal metaplasia. Further progression to dysplasia and gastric cancer is generally believed to be attributable to processes that no longer require the presence of H. pylori. The responses that develop upon H. pylori infection are directly mediated through the action of bacterial virulence factors, which drive the initial events associated with transformation of infected gastric cells. Besides genetic and to date poorly defined environmental factors, alterations in gastric cell stress-adaptive mechanisms due to H. pylori appear to be crucial during chronic infection and gastric disease progression. Firstly, H. pylori infection promotes gastric cell death and reduced epithelial cell turnover in the majority of infected cells, resulting in primary tissue lesions associated with an initial inflammatory response. However, in the remaining gastric cell population, adaptive responses are induced that increase cell survival and proliferation, resulting in the acquisition of potentially malignant characteristics that may lead to precancerous gastric lesions. Thus, deregulation of these intrinsic survival-related responses to H. pylori infection emerge as potential culprits in promoting disease progression. This review will highlight the most relevant cellular adaptive mechanisms triggered upon H. pylori infection, including endoplasmic reticulum stress and the unfolded protein response, autophagy, oxidative stress, and inflammation, together with a subsequent discussion on how these factors may participate in the progression of a precancerous lesion. Finally, this review will shed light on how these mechanisms may be exploited as pharmacological targets, in the perspective of opening up new therapeutic alternatives for non-invasive risk control in gastric cancer.
Keywords: Helicobacter pylori; autophagy; endoplasmic reticulum stress; gastric cancer; inflammation; oxidative stress; precancerous lesion.
Figures

Similar articles
-
[Prevalence of Helicobacter pylori infection and gastric cancer precursor lesions in patients with dyspepsia].Arq Gastroenterol. 2007 Apr-Jun;44(2):93-8. doi: 10.1590/s0004-28032007000200002. Arq Gastroenterol. 2007. PMID: 17962851 Portuguese.
-
[The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].Pol Merkur Lekarski. 2008 Feb;24(140):95-100. Pol Merkur Lekarski. 2008. PMID: 18634262 Polish.
-
Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis.World J Gastroenterol. 2015 Dec 7;21(45):12742-56. doi: 10.3748/wjg.v21.i45.12742. World J Gastroenterol. 2015. PMID: 26668499 Free PMC article. Review.
-
Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis.Am J Gastroenterol. 2001 Jan;96(1):16-26. doi: 10.1111/j.1572-0241.2001.03447.x. Am J Gastroenterol. 2001. PMID: 11197247 Review.
-
Chronic gastritis, intestinal metaplasia, dysplasia and Helicobacter pylori in gastric cancer: putting the pieces together.Ital J Gastroenterol. 1994 Dec;26(9):449-58. Ital J Gastroenterol. 1994. PMID: 7599347 Review.
Cited by
-
Utilization of Galectins by Pathogens for Infection.Front Immunol. 2020 Aug 19;11:1877. doi: 10.3389/fimmu.2020.01877. eCollection 2020. Front Immunol. 2020. PMID: 32973776 Free PMC article. Review.
-
Single-Arm, Prospective, Interventional Study of Helicobacter pylori Eradication Rescue Therapy with Rifabutin, Metronidazole, and Vonoprazan.J Clin Med. 2024 Jun 27;13(13):3774. doi: 10.3390/jcm13133774. J Clin Med. 2024. PMID: 38999340 Free PMC article.
-
Tumor Molecular and Microenvironment Characteristics in EBV-Associated Malignancies as Potential Therapeutic Targets: Focus on Gastric Cancer.Curr Issues Mol Biol. 2022 Nov 18;44(11):5756-5767. doi: 10.3390/cimb44110390. Curr Issues Mol Biol. 2022. PMID: 36421674 Free PMC article. Review.
-
Association Between Gastric Lymphoid Follicles (Precursor Of MALT Lymphomas) And H. pylori Infection At A Referral Hospital In Iran.Clin Exp Gastroenterol. 2019 Oct 29;12:409-413. doi: 10.2147/CEG.S224823. eCollection 2019. Clin Exp Gastroenterol. 2019. PMID: 31754308 Free PMC article.
-
Association of Helicobacter pylori Infection with Autoimmune Thyroid Disease in the Female Sex.J Clin Med. 2023 Aug 6;12(15):5150. doi: 10.3390/jcm12155150. J Clin Med. 2023. PMID: 37568552 Free PMC article.
References
-
- Axten J. M., Medina J. R., Feng Y., Shu A., Romeril S. P., Grant S. W., et al. (2012). Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-p yrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK). J. Med. Chem. 55, 7193–7207. 10.1021/jm300713s - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources